nitroglycerin has been researched along with Cardiovascular Diseases in 131 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to compare the efficacy of nitroglycerin and diltiazem versus nitroglycerin alone in preventing radial artery spasm (RAS) during transradial coronary procedures." | 9.16 | Nitroglycerin plus diltiazem versus nitroglycerin alone for spasm prophylaxis with transradial approach. ( Dharma, S; Pancholy, S; Patel, T; Radadiya, R; Shah, S; Vyas, C, 2012) |
| "In this convenience sample, the response of chest pain to sublingual nitroglycerin was not a reliable indicator of a cardiac etiology." | 9.11 | Changes in the numeric descriptive scale for pain after sublingual nitroglycerin do not predict cardiac etiology of chest pain. ( Amsterdam, EA; Boghos, E; Diercks, DB; Guzman, H; Kirk, JD, 2005) |
| "To determine the effects of pioglitazone (30 mg once daily for 16 weeks) on insulin sensitivity, insulin-mediated vasodilation, vascular inflammatory markers, fat distribution and lipids in Asian Indians and Caucasians of European ancestry." | 7.73 | Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. ( Gerhard-Herman, MD; O'connor, ME; Raji, A; Simonson, DC; Williams, JS, 2006) |
| "The aim of this study was to compare the efficacy of nitroglycerin and diltiazem versus nitroglycerin alone in preventing radial artery spasm (RAS) during transradial coronary procedures." | 5.16 | Nitroglycerin plus diltiazem versus nitroglycerin alone for spasm prophylaxis with transradial approach. ( Dharma, S; Pancholy, S; Patel, T; Radadiya, R; Shah, S; Vyas, C, 2012) |
| " Twenty persons with cardiovascular risk (mean age 50+/-2 years) were treated with atorvastatin (80 mg/day) and FMD/NMD was measured during normoxia, hypoxia and oxygen supplementation before, after 1 day and 3 months." | 5.13 | Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk. ( Frøbert, O; Holmager, P; Jensen, KM; Schmidt, EB; Simonsen, U, 2008) |
| "In this convenience sample, the response of chest pain to sublingual nitroglycerin was not a reliable indicator of a cardiac etiology." | 5.11 | Changes in the numeric descriptive scale for pain after sublingual nitroglycerin do not predict cardiac etiology of chest pain. ( Amsterdam, EA; Boghos, E; Diercks, DB; Guzman, H; Kirk, JD, 2005) |
| " Forearm blood flow (FBF) was measured by strain-gauge plethysmography during reactive hyperemia to assess endothelium-dependent vasodilation and after sublingual nitroglycerin (NTG) administration to assess endothelium-independent vasodilation." | 5.09 | Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. ( Chayama, K; Goto, C; Higashi, Y; Matsuura, H; Nakagawa, K; Ohama, K; Oshima, T; Sanada, M; Sasaki, S, 2001) |
| " "Early entry" therapy with nitrates do not significantly improve survival in myocardial infarction but increases the beneficial effects of the ACE-inhibitor enalapril by 50%." | 4.82 | Organic nitrates in cardiovascular disease. ( Bode-Böger, SM; Kojda, G, 2005) |
| "Cardiovascular diseases and their treatment in the aged are discussed under the headings of ischemic heart disease, hypertension, cardiac failure (with special reference to the use of diuretics and digoxin), infective carditis and thyroid disorders." | 4.75 | Drug therapy for cardiovascular disease in the aged. ( Kennedy, RD, 1975) |
| " Considering the mechanism underlying the vasodilatory response of the brachial artery to reactive hyperemia, hyperemic shear stress (HSS), a stimulus for FMD; nitroglycerine-induced vasodilation (NID), an index of endothelium-independent vasodilation; and baseline brachial artery diameter (BAD) are also involved in vasodilatory response." | 3.85 | Interrelationships Among Flow-Mediated Vasodilation, Nitroglycerine-Induced Vasodilation, Baseline Brachial Artery Diameter, Hyperemic Shear Stress, and Cardiovascular Risk Factors. ( Aibara, Y; Chayama, K; Goto, C; Hashimoto, H; Hida, E; Hidaka, T; Higashi, Y; Iwamoto, Y; Kajikawa, M; Kihara, Y; Kishimoto, S; Maruhashi, T; Matsui, S; Nakashima, A; Noma, K; Oda, N; Yusoff, FM, 2017) |
| "We measured nitroglycerine-induced vasodilation and FMD in 436 subjects who underwent health examinations (mean age, 53 ± 19 years; age range, 19-86 years), including patients with cardiovascular diseases." | 3.79 | Nitroglycerine-induced vasodilation for assessment of vascular function: a comparison with flow-mediated vasodilation. ( Chayama, K; Fujimura, N; Goto, C; Hidaka, T; Higashi, Y; Idei, N; Iwamoto, Y; Kajikawa, M; Kihara, Y; Maruhashi, T; Matsumoto, T; Mikami, S; Nakashima, A; Noma, K; Soga, J, 2013) |
| "We measured brachial IMT, FMD, and nitroglycerine-induced vasodilation by ultrasound in 388 subjects who underwent health examination (mean age, 45±22 years; age range, 19-86), including patients with cardiovascular diseases." | 3.78 | Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors. ( Chayama, K; Fujii, Y; Fujimura, N; Higashi, Y; Idei, N; Iwamoto, Y; Kajikawa, M; Kihara, Y; Maruhashi, T; Matsumoto, T; Mikami, S; Nakashima, A; Noma, K, 2012) |
| "To determine the effects of pioglitazone (30 mg once daily for 16 weeks) on insulin sensitivity, insulin-mediated vasodilation, vascular inflammatory markers, fat distribution and lipids in Asian Indians and Caucasians of European ancestry." | 3.73 | Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. ( Gerhard-Herman, MD; O'connor, ME; Raji, A; Simonson, DC; Williams, JS, 2006) |
| "As part of the Women's Ischemia Syndrome Evaluation (WISE) sponsored by the National Heart, Lung, and Blood Institute, 163 women referred for clinically indicated coronary angiography underwent coronary reactivity assessment with quantitative coronary angiography and intracoronary Doppler flow before and after intracoronary administration of acetylcholine, adenosine, and nitroglycerin and were then followed up for clinical outcomes." | 3.72 | Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). ( Arant, CB; Bairey Merz, CN; Handberg, E; Johnson, BD; Kerensky, RA; McGorray, SP; Olson, MB; Pepine, CJ; Sharaf, BL; Smith, KM; Sopko, G; von Mering, GO; Wessel, TR, 2004) |
| "Children with type 1 diabetes have vascular dysfunction preceding atherosclerosis." | 2.84 | Effect of Metformin on Vascular Function in Children With Type 1 Diabetes: A 12-Month Randomized Controlled Trial. ( Anderson, JJA; Coppin, B; Couper, JJ; Gent, R; Giles, LC; Leggett, CE; Peña, AS, 2017) |
| " As such, a higher dosage of GTN is required in order to achieve the same vasodilatory and antiplatelet effects." | 2.82 | The Generation of Nitric Oxide from Aldehyde Dehydrogenase-2: The Role of Dietary Nitrates and Their Implication in Cardiovascular Disease Management. ( Bosco, F; Cardamone, A; Carresi, C; Coppoletta, A; Gliozzi, M; Macrì, R; Maiuolo, J; Mollace, R; Mollace, V; Muscoli, C; Musolino, V; Oppedisano, F; Palma, E; Scarano, F, 2022) |
| " Only 1 method of preventing nitrate tolerance remains widely accepted: the use of a dosing strategy that provides an interval of no or low nitrate exposure during each 24-h period." | 2.55 | The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics. ( Divakaran, S; Loscalzo, J, 2017) |
| "Erectile dysfunction is a frequent condition in cardiovascular patients." | 2.41 | [Drug treatment of erection disorders in patients with cardiovascular disease]. ( Kingma, JH; Meuleman, EJ, 2001) |
| " In conclusion, transdermal nitroglycerin patches offer a convenient and cosmetically acceptable dosage form which has potential use in stable angina if administered as an intermittent regimen providing a patch-free period each night." | 2.38 | Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use. ( Goa, KL; Langtry, HD; Todd, PA, 1990) |
| " Finally, appropriate dosing strategies are suggested that should eliminate the potential problem of nitrate tolerance." | 2.37 | Nitrates. ( Abrams, J, 1988) |
| "Intermittent nocturnal hypoxemia, obesity and impaired glucose control are early predictors of vascular decline during postmenopause." | 1.91 | Effect of menopause and age on vascular impairment. ( Aittokallio, J; Hautajärvi, T; Heinonen, O; Kalleinen, N; Polo, O; Raitakari, O; Riskumäki, M; Saaresranta, T; Vahlberg, T, 2023) |
| "Childhood obesity is associated with premature cardiovascular complications." | 1.48 | Serum cardiovascular risk biomarkers in pre-pubertal obese children. ( Aggoun, Y; Beghetti, M; Farpour-Lambert, NJ; Galan, K; Mach, F; Maggio, ABR; Montecucco, F, 2018) |
| "Cardiovascular diseases are associated with chronic activation of Rho-associated kinases (ROCKs) and endothelial dysfunction." | 1.37 | Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. ( Chayama, K; Fujii, Y; Fujimura, N; Hata, T; Hidaka, T; Higashi, Y; Idei, N; Kato, H; Kihara, Y; Liao, JK; Maruhashi, T; Mikami, S; Noma, K; Soga, J, 2011) |
| "Endothelium-dependent reactive hyperemia (RH%) and endothelium-independent nitrate hyperemia dilatation (NH%) were measured by strain gauge plethysmography." | 1.35 | Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. ( Antoniades, C; Charakida, M; Latsios, G; Pitsavos, C; Siasos, G; Skoumas, I; Stefanadi, E; Stefanadis, C; Tousoulis, D; Vasiliadou, C, 2009) |
| "In particular, the prevalence of carotid atherosclerosis (28% vs." | 1.35 | High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index. ( Celentano, A; Di Minno, MN; Lupo, T; Migliaresi, P; Orefice, M; Palmieri, V; Valentini, G, 2009) |
| "In vitro and animal studies demonstrate that myeloperoxidase catalytically consumes nitric oxide as a substrate, limiting its bioavailability and function." | 1.32 | Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. ( Brennan, ML; Gokce, N; Goormastic, M; Hazen, SL; Keaney, JF; Mann, SA; Penn, MS; Shishehbor, MH; Vita, JA, 2004) |
| "Type 2 diabetes is associated with an increased risk of cardiovascular disease." | 1.31 | Impaired vascular reactivity is present despite normal levels of von Willebrand factor in patients with uncomplicated Type 2 diabetes. ( Eskildsen, PC; Ihlemann, N; Stokholm, KH, 2002) |
| "Nitrates have been used for the last 130 years to treat and control the symptoms of angina pectoris." | 1.28 | Nitrates. ( Kuhn, M, 1992) |
| " With the conventional tablet and capsule dosage forms, the amount of drug absorbed through the gastrointestinal (GI) tract varies depending on the quantity and types of food in the stomach, on the GI motility and transit time." | 1.27 | Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system. ( Karim, A, 1983) |
| "Nitroglycerin was used to treat systemic or pulmonary hypertension, myocardial ischaemia and ventricular failure." | 1.27 | A profile of intravenous nitroglycerin use in cardiopulmonary bypass surgery. ( Bessette, MC; Cohen, AY; Townsend, GE; Whalley, DG; Wynands, JE, 1983) |
| "Increased mortality from cardio-cerebrovascular diseases among male dynamite workers was reported in 1977 and was supported two years later by findings in a small cohort study from another Swedish dynamite population." | 1.27 | Mortality from cardio-cerebrovascular diseases among dynamite workers--an extended case-referent study. ( Axelson, O; Hogstedt, C, 1984) |
| "Isosorbide dinitrate was independently synthesised in the United States by Harris and colleagues in the 1950s." | 1.27 | Historical aspects of nitrate therapy. ( Berlin, R, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (26.72) | 18.7374 |
| 1990's | 16 (12.21) | 18.2507 |
| 2000's | 43 (32.82) | 29.6817 |
| 2010's | 31 (23.66) | 24.3611 |
| 2020's | 6 (4.58) | 2.80 |
| Authors | Studies |
|---|---|
| Pewowaruk, RJ | 1 |
| Hein, AJ | 1 |
| Carlsson, CM | 1 |
| Korcarz, CE | 1 |
| Gepner, AD | 1 |
| Maiuolo, J | 1 |
| Oppedisano, F | 1 |
| Carresi, C | 1 |
| Gliozzi, M | 1 |
| Musolino, V | 1 |
| Macrì, R | 1 |
| Scarano, F | 1 |
| Coppoletta, A | 1 |
| Cardamone, A | 1 |
| Bosco, F | 1 |
| Mollace, R | 1 |
| Muscoli, C | 1 |
| Palma, E | 1 |
| Mollace, V | 1 |
| Aittokallio, J | 1 |
| Saaresranta, T | 1 |
| Riskumäki, M | 1 |
| Hautajärvi, T | 1 |
| Vahlberg, T | 1 |
| Polo, O | 1 |
| Heinonen, O | 1 |
| Raitakari, O | 1 |
| Kalleinen, N | 1 |
| Maruhashi, T | 8 |
| Kajikawa, M | 5 |
| Kishimoto, S | 3 |
| Hashimoto, H | 2 |
| Takaeko, Y | 1 |
| Yamaji, T | 1 |
| Harada, T | 1 |
| Han, Y | 1 |
| Aibara, Y | 3 |
| Mohamad Yusoff, F | 1 |
| Hidaka, T | 6 |
| Kihara, Y | 9 |
| Chayama, K | 9 |
| Nakashima, A | 6 |
| Goto, C | 6 |
| Tomiyama, H | 1 |
| Takase, B | 1 |
| Kohro, T | 1 |
| Suzuki, T | 1 |
| Ishizu, T | 1 |
| Ueda, S | 1 |
| Yamazaki, T | 1 |
| Furumoto, T | 1 |
| Kario, K | 1 |
| Inoue, T | 1 |
| Koba, S | 1 |
| Watanabe, K | 1 |
| Takemoto, Y | 1 |
| Hano, T | 1 |
| Sata, M | 1 |
| Ishibashi, Y | 1 |
| Node, K | 1 |
| Maemura, K | 1 |
| Ohya, Y | 1 |
| Furukawa, T | 1 |
| Ito, H | 1 |
| Ikeda, H | 1 |
| Yamashina, A | 1 |
| Higashi, Y | 10 |
| Pandurevic, S | 1 |
| Bergamaschi, L | 1 |
| Pizzi, C | 1 |
| Patton, L | 1 |
| Rucci, P | 1 |
| Corzani, F | 1 |
| Cecchetti, C | 1 |
| Pelusi, C | 1 |
| Altieri, P | 1 |
| Vicennati, V | 1 |
| Di Dalmazi, G | 1 |
| Fanelli, F | 1 |
| Macut, D | 1 |
| Pagotto, U | 1 |
| Gambineri, A | 1 |
| Ma, WJ | 1 |
| Yin, YC | 1 |
| Zhang, BK | 1 |
| Li, YJ | 1 |
| Li, WQ | 1 |
| Kopel, T | 1 |
| Kaufman, JS | 1 |
| Hamburg, N | 1 |
| Sampalis, JS | 1 |
| Vita, JA | 3 |
| Dember, LM | 1 |
| Anderson, JJA | 1 |
| Couper, JJ | 1 |
| Giles, LC | 1 |
| Leggett, CE | 1 |
| Gent, R | 1 |
| Coppin, B | 1 |
| Peña, AS | 1 |
| Divakaran, S | 1 |
| Loscalzo, J | 2 |
| Iwamoto, Y | 5 |
| Oda, N | 2 |
| Matsui, S | 2 |
| Yusoff, FM | 1 |
| Noma, K | 6 |
| Hida, E | 2 |
| Maggio, ABR | 1 |
| Farpour-Lambert, NJ | 1 |
| Aggoun, Y | 1 |
| Galan, K | 1 |
| Montecucco, F | 1 |
| Mach, F | 1 |
| Beghetti, M | 1 |
| Soga, J | 4 |
| Fujimura, N | 4 |
| Idei, N | 4 |
| Mikami, S | 4 |
| Matsumoto, T | 3 |
| Hu, YJ | 1 |
| Wei, AN | 1 |
| Chook, P | 1 |
| Yin, Y | 1 |
| Cheng, W | 1 |
| Wu, MJ | 1 |
| Celermajer, DS | 1 |
| Woo, KS | 1 |
| Gilbert, SE | 1 |
| Tew, GA | 1 |
| Bourke, L | 1 |
| Winter, EM | 1 |
| Rosario, DJ | 1 |
| Jones, A | 1 |
| Vennelle, M | 1 |
| Connell, M | 1 |
| McKillop, G | 1 |
| Newby, DE | 1 |
| Douglas, NJ | 1 |
| Riha, RL | 1 |
| Wong, CK | 1 |
| Chen, Y | 1 |
| Ho, LM | 1 |
| Zhen, Z | 1 |
| Siu, CW | 2 |
| Tse, HF | 2 |
| Yiu, KH | 2 |
| Gad, MZ | 1 |
| Abu el Maaty, MA | 1 |
| El-Maraghy, SA | 1 |
| Fahim, AT | 1 |
| Hamdy, MA | 1 |
| Chan, YH | 1 |
| Lau, KK | 1 |
| Yiu, YF | 1 |
| Li, SW | 1 |
| Lam, TH | 1 |
| Lau, CP | 1 |
| Zhang, P | 1 |
| Iwamoto, A | 1 |
| Akcakoyun, M | 1 |
| Kargin, R | 1 |
| Tanalp, AC | 1 |
| Pala, S | 1 |
| Ozveren, O | 1 |
| Akcay, M | 1 |
| Barutcu, I | 1 |
| Kirma, C | 1 |
| Mosca, M | 1 |
| Virdis, A | 1 |
| Tani, C | 1 |
| Ghiadoni, L | 1 |
| Versari, D | 1 |
| Duranti, E | 1 |
| d'Ascanio, A | 1 |
| Salvetti, A | 1 |
| Taddei, S | 1 |
| Bombardieri, S | 1 |
| Sugawara, M | 1 |
| Niki, K | 1 |
| Ohte, N | 1 |
| Okada, T | 1 |
| Harada, A | 1 |
| Stamler, JS | 1 |
| LUND, F | 1 |
| Charakida, M | 1 |
| Tousoulis, D | 1 |
| Skoumas, I | 1 |
| Pitsavos, C | 1 |
| Vasiliadou, C | 1 |
| Stefanadi, E | 1 |
| Antoniades, C | 1 |
| Latsios, G | 1 |
| Siasos, G | 1 |
| Stefanadis, C | 1 |
| Palmieri, V | 1 |
| Migliaresi, P | 1 |
| Orefice, M | 1 |
| Lupo, T | 1 |
| Di Minno, MN | 1 |
| Valentini, G | 1 |
| Celentano, A | 1 |
| Xu, JZ | 1 |
| Zhang, Y | 1 |
| Wu, SN | 1 |
| Niu, WQ | 1 |
| Zhu, DL | 1 |
| Gao, PJ | 1 |
| Rus, R | 1 |
| Buturović-Ponikvar, J | 1 |
| Wierzbicka-Chmiel, J | 1 |
| Mizia-Stec, K | 1 |
| Haberka, M | 1 |
| Chmiel, A | 1 |
| Mizia, M | 1 |
| Gasior, Z | 1 |
| Matsuoka, H | 1 |
| Umei, H | 1 |
| Sugano, R | 1 |
| Fujii, Y | 4 |
| Imaizumi, T | 1 |
| Saihara, K | 1 |
| Hamasaki, S | 1 |
| Ishida, S | 1 |
| Kataoka, T | 1 |
| Yoshikawa, A | 1 |
| Orihara, K | 1 |
| Ogawa, M | 1 |
| Oketani, N | 1 |
| Fukudome, T | 1 |
| Atsuchi, N | 1 |
| Shinsato, T | 1 |
| Okui, H | 1 |
| Kubozono, T | 1 |
| Ichiki, H | 1 |
| Kuwahata, S | 1 |
| Mizoguchi, E | 1 |
| Fujita, S | 1 |
| Takumi, T | 1 |
| Ninomiya, Y | 1 |
| Tomita, K | 1 |
| Tei, C | 1 |
| Nguyen, PK | 1 |
| Katikireddy, CK | 1 |
| McConnell, MV | 1 |
| Kushida, C | 1 |
| Yang, PC | 1 |
| Akamatsu, D | 1 |
| Sato, A | 1 |
| Goto, H | 2 |
| Watanabe, T | 1 |
| Hashimoto, M | 1 |
| Shimizu, T | 1 |
| Sugawara, H | 1 |
| Sato, H | 1 |
| Nakano, Y | 1 |
| Miura, T | 1 |
| Zukeran, T | 1 |
| Serizawa, F | 1 |
| Hamada, Y | 1 |
| Tsuchida, K | 1 |
| Tsuji, I | 1 |
| Satomi, S | 1 |
| Lockhart, CJ | 1 |
| Agnew, CE | 1 |
| McCann, A | 1 |
| Hamilton, PK | 1 |
| Quinn, CE | 1 |
| McCall, DO | 1 |
| Plumb, RD | 1 |
| McClenaghan, VC | 1 |
| McGivern, RC | 1 |
| Harbinson, MT | 1 |
| McVeigh, GE | 1 |
| Mamedov, MN | 1 |
| Digigova, RT | 1 |
| Sharvadze, GG | 1 |
| Ugurchieva, ZO | 1 |
| Kovrigina, MN | 1 |
| Stroeva, MV | 1 |
| Quinaglia, T | 1 |
| Martins, LC | 2 |
| Figueiredo, VN | 1 |
| Santos, RC | 1 |
| Yugar-Toledo, JC | 2 |
| Martin, JF | 1 |
| Demacq, C | 1 |
| Pimenta, E | 1 |
| Calhoun, DA | 1 |
| Moreno, H | 2 |
| Lorbeer, R | 2 |
| Empen, K | 2 |
| Dörr, M | 2 |
| Arndt, M | 1 |
| Schipf, S | 1 |
| Nauck, M | 2 |
| Wallaschofski, H | 2 |
| Felix, SB | 2 |
| Völzke, H | 2 |
| Sandoo, A | 1 |
| Carroll, D | 1 |
| Metsios, GS | 1 |
| Kitas, GD | 1 |
| Veldhuijzen van Zanten, JJ | 1 |
| Hata, T | 1 |
| Kato, H | 1 |
| Liao, JK | 1 |
| Haring, R | 1 |
| Gläser, S | 1 |
| Krebs, A | 1 |
| Reffelmann, T | 1 |
| Ewert, R | 1 |
| Dharma, S | 1 |
| Shah, S | 1 |
| Radadiya, R | 1 |
| Vyas, C | 1 |
| Pancholy, S | 1 |
| Patel, T | 1 |
| Schmidt, K | 1 |
| Neubauer, A | 1 |
| Kolesnik, B | 1 |
| Stasch, JP | 1 |
| Werner, ER | 1 |
| Gorren, AC | 1 |
| Mayer, B | 1 |
| Teragawa, H | 1 |
| Ruel, G | 1 |
| Lapointe, A | 1 |
| Pomerleau, S | 1 |
| Couture, P | 1 |
| Lemieux, S | 1 |
| Lamarche, B | 1 |
| Couillard, C | 1 |
| Hisasue, S | 1 |
| Sato, Y | 1 |
| Tsukamoto, T | 1 |
| Gori, T | 1 |
| Parker, JD | 2 |
| Campuzano, R | 1 |
| Moya, JL | 1 |
| García-Lledó, A | 1 |
| Salido, L | 1 |
| Guzmán, G | 1 |
| Tomas, JP | 1 |
| Catalán, P | 1 |
| Muriel, A | 1 |
| Asín, E | 1 |
| PAUL, O | 1 |
| KELSER, GA | 1 |
| Lubner, GC | 1 |
| Girdler, SS | 1 |
| Hinderliter, AL | 1 |
| Wells, EC | 1 |
| Sherwood, A | 1 |
| Grewen, KM | 1 |
| Light, KC | 1 |
| FOX, EL | 1 |
| WRIGHT, IS | 1 |
| RUSSEK, HI | 1 |
| ANDERSON, WH | 1 |
| DOERNER, AA | 1 |
| KEYS, A | 1 |
| SIMONSON, E | 1 |
| HOPKINS, RW | 1 |
| von Mering, GO | 1 |
| Arant, CB | 1 |
| Wessel, TR | 1 |
| McGorray, SP | 1 |
| Bairey Merz, CN | 1 |
| Sharaf, BL | 1 |
| Smith, KM | 1 |
| Olson, MB | 1 |
| Johnson, BD | 1 |
| Sopko, G | 1 |
| Handberg, E | 1 |
| Pepine, CJ | 1 |
| Kerensky, RA | 1 |
| Brennan, ML | 1 |
| Gokce, N | 1 |
| Mann, SA | 1 |
| Goormastic, M | 1 |
| Shishehbor, MH | 1 |
| Penn, MS | 1 |
| Keaney, JF | 1 |
| Hazen, SL | 1 |
| KRASNO, LR | 1 |
| IVY, AC | 1 |
| Spijkerman, AM | 1 |
| Smulders, YM | 1 |
| Kostense, PJ | 1 |
| Henry, RM | 1 |
| Becker, A | 1 |
| Teerlink, T | 1 |
| Jakobs, C | 1 |
| Dekker, JM | 1 |
| Nijpels, G | 1 |
| Heine, RJ | 1 |
| Bouter, LM | 1 |
| Stehouwer, CD | 1 |
| Pauca, AL | 1 |
| Kon, ND | 1 |
| O'Rourke, MF | 1 |
| Silvestri, A | 1 |
| Gambacciani, M | 1 |
| Vitale, C | 1 |
| Monteleone, P | 1 |
| Ciaponi, M | 1 |
| Fini, M | 1 |
| Genazzani, AR | 1 |
| Mercuro, G | 1 |
| Rosano, GM | 1 |
| Diercks, DB | 1 |
| Boghos, E | 1 |
| Guzman, H | 1 |
| Amsterdam, EA | 1 |
| Kirk, JD | 1 |
| Bode-Böger, SM | 1 |
| Kojda, G | 1 |
| Zheng, H | 1 |
| Huang, X | 1 |
| Zhang, Q | 1 |
| Katz, SD | 1 |
| Paradisi, G | 1 |
| Biaggi, A | 1 |
| Savone, R | 1 |
| Ianniello, F | 1 |
| Tomei, C | 1 |
| Caforio, L | 1 |
| Caruso, A | 1 |
| Raji, A | 1 |
| Gerhard-Herman, MD | 1 |
| Williams, JS | 1 |
| O'connor, ME | 1 |
| Simonson, DC | 1 |
| Lane, HA | 1 |
| Grace, F | 1 |
| Smith, JC | 1 |
| Morris, K | 1 |
| Cockcroft, J | 1 |
| Scanlon, MF | 2 |
| Davies, JS | 2 |
| Greenland, P | 1 |
| Dogra, G | 1 |
| Irish, A | 1 |
| Chan, D | 1 |
| Watts, G | 1 |
| Fink, B | 1 |
| Dikalov, S | 1 |
| Fink, N | 1 |
| Shechter, M | 2 |
| Marai, I | 2 |
| Marai, S | 1 |
| Sherer, Y | 1 |
| Sela, BA | 1 |
| Feinberg, MS | 2 |
| Rubinstein, A | 1 |
| Shoenfeld, Y | 1 |
| Sahin, G | 1 |
| Yalcin, AU | 1 |
| Akcar, N | 1 |
| Frøbert, O | 1 |
| Holmager, P | 1 |
| Jensen, KM | 1 |
| Schmidt, EB | 1 |
| Simonsen, U | 1 |
| Rubira, MC | 1 |
| Consolim-Colombo, FM | 1 |
| Rabelo, ER | 1 |
| Casarini, D | 1 |
| Coimbra, SR | 1 |
| Krieger, EM | 1 |
| Irigoyen, MC | 1 |
| Anderson, T | 1 |
| Charbonneau, F | 1 |
| Chan, S | 1 |
| Lonn, E | 1 |
| Andrade, AC | 1 |
| Ladeia, AM | 1 |
| Netto, EM | 1 |
| Mascarenhas, A | 1 |
| Cotter, B | 1 |
| Benson, CA | 1 |
| Badaró, R | 1 |
| Issachar, A | 1 |
| Koren-Morag, N | 1 |
| Freinark, D | 1 |
| Shahar, Y | 1 |
| Shechter, A | 1 |
| Cárdenas Loaeza, M | 1 |
| Karim, A | 1 |
| Townsend, GE | 1 |
| Wynands, JE | 1 |
| Whalley, DG | 1 |
| Cohen, AY | 1 |
| Bessette, MC | 1 |
| Spector, R | 1 |
| Hogstedt, C | 1 |
| Axelson, O | 1 |
| Abrams, J | 3 |
| Tritthart, HA | 1 |
| Steingart, RM | 1 |
| Wexler, JP | 1 |
| Blaufox, MD | 1 |
| Bourbonnais, F | 1 |
| Halawa, B | 1 |
| Utoh, J | 1 |
| Miyauchi, Y | 1 |
| Obayashi, H | 1 |
| Hirata, T | 1 |
| Vallance, P | 1 |
| Moncada, S | 1 |
| Chen, CH | 1 |
| Ting, CT | 1 |
| Nussbacher, A | 1 |
| Nevo, E | 1 |
| Kass, DA | 1 |
| Pak, P | 1 |
| Wang, SP | 1 |
| Chang, MS | 1 |
| Yin, FC | 1 |
| Eagle, KA | 1 |
| Brundage, BH | 1 |
| Chaitman, BR | 1 |
| Ewy, GA | 1 |
| Fleisher, LA | 1 |
| Hertzer, NR | 1 |
| Leppo, JA | 1 |
| Ryan, T | 1 |
| Schlant, RC | 1 |
| Spencer, WH | 1 |
| Spittell, JA | 1 |
| Twiss, RD | 1 |
| Ritchie, JL | 1 |
| Cheitlin, MD | 1 |
| Gardner, TJ | 1 |
| Garson, A | 1 |
| Lewis, RP | 1 |
| Gibbons, RJ | 1 |
| O'Rourke, RA | 1 |
| Ryan, TJ | 1 |
| Parker, JA | 1 |
| Kawano, H | 1 |
| Motoyama, T | 1 |
| Kugiyama, K | 1 |
| Hirashima, O | 1 |
| Ohgushi, M | 1 |
| Fujii, H | 1 |
| Ogawa, H | 1 |
| Yasue, H | 1 |
| Harrison, DG | 1 |
| Johansson, J | 3 |
| Jensen-Urstad, K | 3 |
| Jensen-Urstad, M | 2 |
| Evans, LM | 1 |
| Goodfellow, J | 1 |
| Rees, JA | 1 |
| Meuleman, EJ | 1 |
| Kingma, JH | 1 |
| Sanada, M | 1 |
| Sasaki, S | 1 |
| Nakagawa, K | 1 |
| Matsuura, H | 1 |
| Ohama, K | 1 |
| Oshima, T | 1 |
| Irwin, MG | 1 |
| Ng, JK | 1 |
| Duchna, HW | 1 |
| Guilleminault, C | 1 |
| Stoohs, RA | 1 |
| Orth, M | 1 |
| de Zeeuw, J | 1 |
| Schultze-Werninghaus, G | 1 |
| Rasche, K | 1 |
| Kinlay, S | 1 |
| Creager, MA | 1 |
| Fukumoto, M | 1 |
| Hikita, H | 1 |
| Fang, JC | 1 |
| Selwyn, AP | 1 |
| Ganz, P | 1 |
| Ihlemann, N | 1 |
| Stokholm, KH | 1 |
| Eskildsen, PC | 1 |
| Kennedy, RD | 1 |
| Glasser, SP | 1 |
| Hathaway, JA | 1 |
| Arora, BK | 1 |
| McIntyre, KM | 1 |
| Lambrew, CT | 1 |
| Freeman, J | 1 |
| Stayner, LT | 1 |
| Dannenberg, AL | 1 |
| Thun, M | 1 |
| Reeve, G | 1 |
| Bloom, TF | 1 |
| Boeniger, M | 1 |
| Halperin, W | 1 |
| Kuhn, M | 1 |
| Shub, C | 1 |
| Todd, PA | 1 |
| Goa, KL | 1 |
| Langtry, HD | 1 |
| Kristensen, TS | 1 |
| Lindvall, K | 1 |
| Berlin, R | 1 |
| Kamei, K | 1 |
| Aizawa, Y | 1 |
| Shibata, A | 1 |
| Takeuchi, Y | 1 |
| Ishii, M | 1 |
| Langnickel, R | 1 |
| Bluth, R | 1 |
| Almeyda, J | 1 |
| Levantine, A | 1 |
| Fiehring, H | 1 |
| Vormittag, E | 1 |
| Zekert, F | 1 |
| Kohn, P | 1 |
| Grabner, H | 1 |
| Vormittag, D | 1 |
| Takenaka, F | 1 |
| Lapin, BA | 1 |
| Cherkovich, GM | 1 |
| Iakovleva, LA | 1 |
| Heuillet, G | 1 |
| Saadjian, A | 1 |
| Couve, M | 1 |
| Soulier, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Flow-mediated Arterial Dilatation, Hypertension, Endothelin-1 (ET-1) and Soluble Intercellular Adhesion Molecule (sICAM-1) in Obese Adolescents[NCT05951894] | 70 participants (Actual) | Observational [Patient Registry] | 2023-08-01 | Completed | |||
| Safety and Tolerability of Topical Nitroglycerin to Dilate the Radial Artery Prior to Transradial Coronary Angiography[NCT05239013] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2022-05-01 | Not yet recruiting | ||
| Understanding the Role of the External Carotid Artery in the Pathophysiology of Migraine Pain[NCT03026101] | 20 participants (Anticipated) | Interventional | 2017-01-31 | Enrolling by invitation | |||
| Perioperative Endothelial Dysfunction in Patients Undergoing Minor Abdominal Surgery. The POETRY Minor Study.[NCT02690233] | 60 participants (Actual) | Observational | 2016-02-29 | Completed | |||
| Effect of Androgen Deprivation Therapy on Left Ventricular Function in Prostate Cancer Patients and Survivors[NCT03275181] | 60 participants (Anticipated) | Observational | 2017-08-01 | Recruiting | |||
| The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans[NCT02490124] | 7 participants (Actual) | Observational | 2014-12-31 | Completed | |||
| The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes[NCT03174288] | 32 participants (Actual) | Interventional | 2015-08-31 | Completed | |||
| Do Patients Need Pre-Procedural Fasting for Coronary Artery Procedures?[NCT02562638] | 240 participants (Anticipated) | Interventional | 2015-10-31 | Not yet recruiting | |||
| [NCT00000554] | Phase 3 | 0 participants | Interventional | 2001-05-31 | Completed | ||
| Non-invasive Fractional Flow Reserve CT (FFRCT) Scan for the Study of Coronary Vaso-motion[NCT02809157] | 10 participants (Anticipated) | Observational | 2014-10-31 | Active, not recruiting | |||
| The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease[NCT00570024] | 145 participants (Actual) | Interventional | 2006-01-31 | Completed | |||
| WISE Ancillary Study Data Analyses: Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis[NCT00600106] | 37 participants (Actual) | Interventional | 1999-12-31 | Completed | |||
| Nitrative Stress in Heart Failure: The Cleveland Heart and Metabolic Prevention Study (CHAMPS)[NCT03012022] | 1,208 participants (Actual) | Observational | 2010-11-30 | Active, not recruiting | |||
| Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study[NCT02333240] | 101 participants (Actual) | Interventional | 2015-04-30 | Completed | |||
| Gender-Specific Effects of Physiologic GH Administration on Cardiovascular Risk Factors in Women With Growth Hormone Deficiency[NCT00136032] | 63 participants (Actual) | Interventional | 2002-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Endothelial dysfunction refers to altered vasoactive, anticoagulant, and anti-inflammatory properties of endothelium, and dysregulated vascular growth remodeling that results from a loss of nitric oxide (NO) bioactivity in the endothelium. Brachial Artery Reactivity Testing (BART), high-frequency ultrasonographic imaging of the brachial artery, evaluates flow-mediated vasodilation (FMD), an endothelium-dependent function. The technique provokes the release of nitric oxide, resulting in vasodilation that can be quantitated as an index of endothelial dysfunction.~Flow-mediated vasodilation is typically expressed as the change in post-stimulus diameter as a percentage of the baseline diameter [diameter after cuff deflation - baseline diameter / baseline diameter) x 100]." (NCT00600106)
Timeframe: Baseline
| Intervention | percentage of pre-stimulus diameter (Mean) |
|---|---|
| Hormone Replacement Therapy | 8.2 |
| Placebo | 8.8 |
"Endothelial dysfunction refers to altered vasoactive, anticoagulant, and anti-inflammatory properties of endothelium, and dysregulated vascular growth remodeling that results from a loss of nitric oxide (NO) bioactivity in the endothelium. Brachial Artery Reactivity Testing (BART), high-frequency ultrasonographic imaging of the brachial artery, evaluates flow-mediated vasodilation (FMD), an endothelium-dependent function. The technique provokes the release of nitric oxide, resulting in vasodilation that can be quantitated as an index of vasomotor function.~Flow-mediated vasodilation is typically expressed as the change in post-stimulus diameter as a percentage of the baseline diameter [diameter after cuff deflation - baseline diameter / baseline diameter) x 100]." (NCT00600106)
Timeframe: 12 weeks
| Intervention | percentage of pre-stimulus diameter (Mean) |
|---|---|
| Hormone Replacement Therapy | 8.8 |
| Placebo | 7.3 |
Inducible myocardial ischemia measured by P-31 gated magnetic resonance cardiac spectroscopy (MRS) is reported as change (∆) in PCr/ATP ratio, with isometric submaximal handgrip stress. PCr/ATP ratio defined as (stress-[average of rest and recovery periods]) / average of rest and recover periods X 100, and expressed as % mean ± SD. For this trial, myocardial ischemia was pre-specified as a fall in quantitative PCR/ATP ratio >20% from rest, and a lower value is considered indicative of greater ischemia. (NCT00600106)
Timeframe: 12 weeks
| Intervention | percent change in PCR/ATP ratio (Mean) |
|---|---|
| Hormone Replacement Therapy | -7.7 |
| Placebo | 1.1 |
Inducible myocardial ischemia measured by P-31 gated magnetic resonance cardiac spectroscopy (MRS) is reported as change (∆) in PCr/ATP ratio, with isometric submaximal handgrip stress. PCr/ATP ratio defined as (stress-[average of rest and recovery periods]) / average of rest and recover periods X 100, and expressed as % mean ± SD. For this trial, myocardial ischemia was pre-specified as a fall in quantitative PCR/ATP ratio >20% from rest, and a lower value is considered indicative of greater ischemia. (NCT00600106)
Timeframe: Baseline
| Intervention | percent changed in PCR/ATP ratio (Mean) |
|---|---|
| Hormone Replacement Therapy | -13.8 |
| Placebo | -7.0 |
"Physical functional disability measured by exercise stress testing. Functional capacity was measured as metabolism equivalents (METs), exercise duration, and exercise-induced chest pain.~In electrocardiography, the ST segment connects the QRS complex and the T wave and has duration of 80 to 120 ms. It should be essentially level with the PR and TP segment. The normal ST segment has a slight upward concavity. Flat, downsloping, or depressed ST segment may indicate coronary ishcemia. Positive treadmill exercise stress test (>1.0 mm horizontal / downsloping or >1.5 upsloping ST segment depression measured 0.08 msec after the J point)." (NCT00600106)
Timeframe: Baseline
| Intervention | mm (Mean) |
|---|---|
| Hormone Replacement Therapy | -0.79 |
| Placebo | -0.79 |
Physical functional disability measured by exercise stress testing. Functional capacity was measured as metabolism equivalents (METs), exercise duration, and exercise-induced chest pain. (NCT00600106)
Timeframe: Baseline
| Intervention | metabolism equivalents (Mean) |
|---|---|
| Hormone Replacement Therapy | 6.1 |
| Placebo | 5.8 |
Physical functional disability measured by exercise stress testing. Functional capacity was measured as metabolism equivalents (METs), exercise duration, and exercise-induced chest pain. (NCT00600106)
Timeframe: Exit (12 weeks)
| Intervention | metabolism equivalents (Mean) |
|---|---|
| Hormone Replacement Therapy | 6.1 |
| Placebo | 5.4 |
Physical functional disability measured by exercise stress testing. Functional capacity was measured as metabolism equivalents (METs), exercise duration, and exercise-induced chest pain. A MET is defined as the resting metabolic rate, that is, the amount or oxygen consumet at rest, sitting quietly in a chair, approximately 3.5 ml O2 / kg / min (1.2 kcallmin for a 70-kg person). As such, work at METs requires twice the resting metabolism or 7.0 ml O2/kg/min, and so on. (NCT00600106)
Timeframe: Baseline
| Intervention | metabolism equivalents (Mean) |
|---|---|
| Hormone Replacement Therapy | 5.4 |
| Placebo | 5.4 |
Physical functional disability measured by exercise stress testing. Functional capacity was measured as metabolism equivalents (METs), exercise duration, and exercise-induced chest pain. A MET is defined as the resting metabolic rate, that is, the amount or oxygen consumet at rest, sitting quietly in a chair, approximately 3.5 ml O2 / kg / min (1.2 kcallmin for a 70-kg person). As such, work at METs requires twice the resting metabolism or 7.0 ml O2/kg/min, and so on. (NCT00600106)
Timeframe: Exit at 12 weeks
| Intervention | metabolism equivalents (Mean) |
|---|---|
| Hormone Replacement Therapy | 6.1 |
| Placebo | 5.4 |
"Physical functional disability measured by exercise stress testing. Functional capacity was measured as metabolism equivalents (METs), exercise duration, and exercise-induced chest pain.~In electrocardiography, the ST segment connects the QRS complex and the T wave and has duration of 80 to 120 ms. It should be essentially level with the PR and TP segment. The normal ST segment has a slight upward concavity. Flat, downsloping, or depressed ST segment may indicate coronary ishcemia. Positive treadmill exercise stress test (>1.0 mm horizontal / downsloping or >1.5 upsloping ST segment depression measured 0.08 msec after the J point)." (NCT00600106)
Timeframe: Exit (12 weeks)
| Intervention | mm (Mean) |
|---|---|
| Hormone Replacement Therapy | -1.05 |
| Placebo | -0.63 |
"Quality of life assessed by cardiac symptoms and psychological questionnaires (SF 36 scale - Short Form Health Survey) The SF-36 includes one multi-item scale that assesses eight health concepts: 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 6) limitations in usual role activities because of emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions.~Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability." (NCT00600106)
Timeframe: 12 weeks
| Intervention | units on a scale (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Physical functioning | Role-physical | Role-emotional | Bodily pain | General health | Mental health | Vitality | Social functioning | |
| Hormone Replacement Therapy | 59.4 | 58.8 | 76.5 | 54.5 | 55.2 | 66.4 | 35.6 | 59.4 |
| Placebo | 44.4 | 25.0 | 66.7 | 41.5 | 57.2 | 69.3 | 41.2 | 56.1 |
"Quality of life assessed by cardiac symptoms and psychological questionnaires (SF 36 scale - Short Form Health Survey) The SF-36 includes one multi-item scale that assesses eight health concepts: 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 6) limitations in usual role activities because of emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions.~Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability." (NCT00600106)
Timeframe: Baseline
| Intervention | units on a scale (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Physical functioning | Role-physical | Role-emotional | Bodily pain | General health | Mental health | Vitality | Social functioning | |
| Hormone Replacement Therapy | 60.8 | 54.2 | 70.3 | 53.3 | 55.4 | 66.7 | 35.6 | 59.4 |
| Placebo | 43.8 | 37.3 | 66.7 | 42.1 | 57.4 | 65.7 | 42.9 | 53.2 |
Quality of life assessed by menopausal symptoms and psychological questionnaires (NCT00600106)
Timeframe: 12 weeks
| Intervention | percent of participants (Number) | ||||
|---|---|---|---|---|---|
| Hot flushes or flashing | Poor memory | Change in sexual desire | Vaginal dryness | Avoiding intimacy | |
| Hormone Replacement Therapy | 41 | 59 | 35 | 35 | 24 |
| Placebo | 89 | 78 | 67 | 67 | 56 |
Quality of life assessed by menopausal symptoms and psychological questionnaires (NCT00600106)
Timeframe: Baseline
| Intervention | percent of participants (Number) | ||||
|---|---|---|---|---|---|
| Hot flushes or flashing | Poor memory | Change in sexual desire | Vaginal dryness | Avoiding intimacy | |
| Hormone Replacement Therapy | 89 | 76 | 50 | 44 | 39 |
| Placebo | 68 | 53 | 37 | 58 | 37 |
20 reviews available for nitroglycerin and Cardiovascular Diseases
| Article | Year |
|---|---|
The Generation of Nitric Oxide from Aldehyde Dehydrogenase-2: The Role of Dietary Nitrates and Their Implication in Cardiovascular Disease Management.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Cardiovascular Diseases; Humans; Nitr | 2022 |
Calcitonin gene‑related peptide‑mediated pharmacological effects in cardiovascular and gastrointestinal diseases (Review).
Topics: Calcitonin Gene-Related Peptide; Cardiovascular Diseases; Gastrointestinal Diseases; Gene Expression | 2021 |
The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Drug Administration Routes; Humans; Nitroge | 2017 |
Assessment of endothelium-independent vasodilation: from methodology to clinical perspectives.
Topics: Angiography; Atherosclerosis; Brachial Artery; Cardiovascular Diseases; Coronary Vessels; Endotheliu | 2018 |
[Detection of erectile dysfunction and peculiarities of its treatment in men with high cardiovascular risk].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Cardiovascul | 2010 |
[Adverse events and drug interactions of sildenafil].
Topics: Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Interactions; Erectile Dysfun | 2002 |
The puzzle of nitrate tolerance: pieces smaller than we thought?
Topics: Animals; Autonomic Nervous System; Blood Vessels; Cardiovascular Diseases; Drug Tolerance; Endotheli | 2002 |
Organic nitrates in cardiovascular disease.
Topics: Angina, Unstable; Animals; Cardiovascular Diseases; Cyclic GMP; Enalapril; Endothelium, Vascular; He | 2005 |
Nitrate tolerance and dependence.
Topics: Ambulatory Care; Angina Pectoris; Animals; Cardiovascular Diseases; Dogs; Drug Tolerance; Heart Fail | 1980 |
[Complications associated with sudden withdrawal of various drugs used in the treatment of cardiovascular diseases].
Topics: Cardiovascular Diseases; Clonidine; Guanethidine; Humans; Nitroglycerin; Nitroprusside; Propranolol; | 1981 |
Organic nitrates: new formulations and their clinical advantages.
Topics: Cardiovascular Diseases; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Randomized Controlle | 1996 |
Endothelial function and oxidant stress.
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hydrogen Peroxide; | 1997 |
[Drug treatment of erection disorders in patients with cardiovascular disease].
Topics: Cardiovascular Diseases; Contraindications; Drug Interactions; Erectile Dysfunction; Humans; Isosorb | 2001 |
Drug therapy for cardiovascular disease in the aged.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Benzothiadiazines; C | 1975 |
Stable angina pectoris: 3. Medical treatment.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Cardi | 1990 |
Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.
Topics: Administration, Cutaneous; Angina Pectoris; Cardiovascular Diseases; Humans; Nitroglycerin | 1990 |
Work environment and cardiovascular diseases. A short review of the literature.
Topics: Cadmium; Carbon Disulfide; Cardiovascular Diseases; Cold Temperature; Electromagnetic Fields; Enviro | 1989 |
Evaluation of effects of nitroglycerin therapy by echocardiography.
Topics: Cardiovascular Diseases; Echocardiography; Humans; Nitroglycerin | 1986 |
Nitrates.
Topics: Animals; Cardiovascular Diseases; Coronary Disease; Heart Failure; Humans; Nitrates; Nitroglycerin | 1988 |
Cutaneous reactions to cardiovascular drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides; | 1973 |
21 trials available for nitroglycerin and Cardiovascular Diseases
| Article | Year |
|---|---|
Effect of Metformin on Vascular Function in Children With Type 1 Diabetes: A 12-Month Randomized Controlled Trial.
Topics: Adolescent; Blood Vessels; Brachial Artery; Cardiovascular Diseases; Child; Diabetes Mellitus, Type | 2017 |
The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized controlled trial in patients without cardiovascular disease.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Aorta; Blood Flow Velocity; Cardiovascular Di | 2013 |
Influence of Nitroglycerin on Coronary Artery CT Imaging in Cardiovascular Diseases.
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Angiography; Coronary Vessels; Female; Humans; Male; | 2015 |
Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cardiovascular Diseases; Case-Control Stud | 2010 |
Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea.
Topics: Adult; Aged; Asymptomatic Diseases; Brachial Artery; California; Cardiovascular Diseases; Continuous | 2010 |
The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study.
Topics: Acetylcholine; Adult; Aged; Arthritis, Rheumatoid; Cardiovascular Diseases; Cross-Sectional Studies; | 2011 |
Nitroglycerin plus diltiazem versus nitroglycerin alone for spasm prophylaxis with transradial approach.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Cardiovascular Diseases; Diltiazem; Drug Thera | 2012 |
Flow-mediated vasodilation and anatomical variation of the brachial artery (double brachial artery) in healthy subjects and patients with cardiovascular disease.
Topics: Adult; Aged; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Female; Humans; Male; Mi | 2013 |
Evidence that cranberry juice may improve augmentation index in overweight men.
Topics: Adult; Albuterol; Beverages; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological P | 2013 |
Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Blood Pressure; Brachial Artery; Cardi | 2004 |
S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study.
Topics: Aged; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; En | 2005 |
Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dehydroepiandrosterone; Double-Blind M | 2005 |
Changes in the numeric descriptive scale for pain after sublingual nitroglycerin do not predict cardiac etiology of chest pain.
Topics: Administration, Sublingual; Cardiovascular Diseases; Chest Pain; Electrocardiography; Female; Humans | 2005 |
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-B | 2006 |
Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients.
Topics: Acetylcysteine; Adult; Antioxidants; Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular | 2007 |
Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk.
Topics: Administration, Inhalation; Adult; Atorvastatin; Brachial Artery; Cardiovascular Diseases; Cholester | 2008 |
The effect of large unilamellar vesicles on vascular function in patients with coronary atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cholesterol; Coronary Artery Disease; Endot | 2008 |
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brachial Artery; Cardiovascular Diseases; Diagnostic Tec | 2009 |
Hemodynamic effects of bolus nicorandil compared with nitroglycerin.
Topics: Aged; Cardiovascular Diseases; Emergencies; Female; Hemodynamics; Humans; Male; Middle Aged; Niacina | 1995 |
Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women.
Topics: Blood Pressure; Cardiovascular Diseases; Endothelium, Vascular; Estrogen Replacement Therapy; Female | 2001 |
A noninvasive method of predicting pulmonary-capillary wedge pressure.
Topics: Blood Pressure; Cardiovascular Diseases; Hemodynamics; Humans; Methods; Nitroglycerin; Prospective S | 1992 |
90 other studies available for nitroglycerin and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of nitroglycerin-induced vasodilation on elastic and muscular artery stiffness in older Veterans.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Carotid Art | 2022 |
Effect of menopause and age on vascular impairment.
Topics: Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular; Female; Humans; Hypoxia; Menopause; | 2023 |
Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brachial Artery; Cardiovascular Diseases; Endothelium, V | 2020 |
Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross-Sectional Stu | 2021 |
Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
Topics: Adult; Aged; Brachial Artery; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Stud | 2017 |
Interrelationships Among Flow-Mediated Vasodilation, Nitroglycerine-Induced Vasodilation, Baseline Brachial Artery Diameter, Hyperemic Shear Stress, and Cardiovascular Risk Factors.
Topics: Adult; Aged; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular; F | 2017 |
Serum cardiovascular risk biomarkers in pre-pubertal obese children.
Topics: Adiponectin; Behavior Therapy; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Ca | 2018 |
Nitroglycerine-induced vasodilation for assessment of vascular function: a comparison with flow-mediated vasodilation.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Angiography; Atherosclerosis; Blo | 2013 |
Impact of non-cardiovascular surgery on reactive hyperaemia and arterial endothelial function.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cardiovascular Diseas | 2013 |
Assessment of endothelial dysfunction by flow-mediated dilatation in men on long-term androgen deprivation therapy for prostate cancer.
Topics: Aged; Androgen Antagonists; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Case-Cont | 2013 |
The effects of hyperuricaemia on flow-mediated and nitroglycerin-mediated dilatation in high-risk patients.
Topics: Adult; Aged; Aged, 80 and over; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; D | 2014 |
Investigating the cardio-protective abilities of supplemental L-arginine on parameters of endothelial function in a hypercholesterolemic animal model.
Topics: Amidohydrolases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Cardiotonic Agents; Ca | 2014 |
The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Topics: Aged; Atrial Fibrillation; Body Mass Index; Cardiovascular Diseases; Carotid Intima-Media Thickness; | 2014 |
Combination of Flow-Mediated Vasodilation and Nitroglycerine-Induced Vasodilation Is More Effective for Prediction of Cardiovascular Events.
Topics: Adult; Aged; Atherosclerosis; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Cohort | 2016 |
Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; | 2008 |
Vascular reactivity in patients with undifferentiated connective tissue diseases.
Topics: Acetylcholine; Adult; Brachial Artery; Cardiovascular Diseases; Case-Control Studies; Connective Tis | 2009 |
Clinical usefulness of wave intensity analysis.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Echocardiogra | 2009 |
Nitroglycerin-mediated S-nitrosylation of proteins: a field comes full cycle.
Topics: Animals; Cardiovascular Diseases; Humans; Microcirculation; Nitroglycerin; Nitroso Compounds; Protei | 2008 |
Percutaneous nitroglycerin treatment in cases of peripheral circulatory disorders, especially Raynaud's disease.
Topics: Administration, Cutaneous; Cardiovascular Diseases; Humans; Nitroglycerin; Raynaud Disease | 1948 |
Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia.
Topics: Adolescent; Age Factors; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studi | 2009 |
High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Brachial Artery; Cardiovascular Diseases; Carotid Art | 2009 |
Impaired endothelial function in hypertensive patients with target organ damage.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Brachial Artery; Card | 2009 |
Intima media thickness and endothelial function in chronic hemodialysis patients.
Topics: Adult; Age Factors; Brachial Artery; Cardiovascular Diseases; Carotid Arteries; Diabetes Mellitus; E | 2009 |
The relationship between cardiovascular risk estimated by use of SCORE system and intima media thickness and flow mediated dilatation in a low risk population.
Topics: Adult; Age Factors; Brachial Artery; Cardiovascular Diseases; Carotid Artery, Common; Endothelium, V | 2009 |
Enjoying hobbies is related to desirable cardiovascular effects.
Topics: Acetylcholine; Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Angiogr | 2010 |
Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease.
Topics: Aged; Atherosclerosis; Brachial Artery; Cardiovascular Diseases; Humans; Kinetics; Middle Aged; Nitr | 2010 |
Impaired flow-mediated dilatation response in uncomplicated Type 1 diabetes mellitus: influence of shear stress and microvascular reactivity.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Diabetes | 2011 |
Impaired flow-mediated dilatation response in uncomplicated Type 1 diabetes mellitus: influence of shear stress and microvascular reactivity.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Diabetes | 2011 |
Impaired flow-mediated dilatation response in uncomplicated Type 1 diabetes mellitus: influence of shear stress and microvascular reactivity.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Diabetes | 2011 |
Impaired flow-mediated dilatation response in uncomplicated Type 1 diabetes mellitus: influence of shear stress and microvascular reactivity.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Diabetes | 2011 |
Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Amb | 2011 |
Association between glycosylated haemoglobin A(1c) and endothelial function in an adult non-diabetic population.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Case-C | 2011 |
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Aged; Blood Pressure; Blotting, Western; Body | 2011 |
Association of testosterone levels with endothelial function in men: results from a population-based study.
Topics: Adult; Aged; Aged, 80 and over; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; E | 2012 |
Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation.
Topics: Animals; Aorta; Biopterins; Cardiovascular Diseases; Cells, Cultured; Cyclic GMP; Endothelial Cells; | 2012 |
Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Brachial Artery; Cardiovascular Diseases; Carotid A | 2012 |
[Endothelial dysfunction and intima-media thickness in relation to cardiovascular risk factors in patients without clinical manifestations of atherosclerosis].
Topics: Aged; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Female; Humans; Male; Middle | 2003 |
INTRACTABLE ANGINA.
Topics: Anemia; Angina Pectoris; Anticoagulants; Anxiety; Cardiac Surgical Procedures; Cardiovascular Diseas | 1963 |
MASQUERADES ENCOUNTERED IN THE DIFFERENTIAL DIAGNOSIS OF CARDIOVASCULAR AND GASTROINTESTINAL DISORDERS.
Topics: Angina Pectoris; Cardiovascular Diseases; Cholecystitis; Coronary Disease; Diagnosis, Differential; | 1964 |
[Therapeutic compliance: new frontier in the efficiency of treatment. The example of nitroglycerin transdermal systems].
Topics: Cardiovascular Diseases; Humans; Nitroglycerin; Patient Compliance; Vasodilator Agents | 2003 |
Therapy with nitrates: increasing evidence of vascular toxicity.
Topics: Cardiovascular Diseases; Drug Tolerance; Endothelium, Vascular; Humans; Nitrates; Nitroglycerin; Rea | 2003 |
The nitroglycerin-flicker test.
Topics: Cardiovascular Diseases; Diagnostic Techniques, Cardiovascular; Humans; Nitroglycerin | 1951 |
Significance of the nitroglycerin-flicker fusion response in normal subjects and patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Diagnostic Techniques, Cardiovascular; Flicker Fusion; Humans; Nitroglyceri | 1951 |
The flicker fusion frequency and its response to nitroglycerin in normal subjects and in patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Diagnostic Techniques, Cardiovascular; Flicker Fusion; Humans; Nitroglyceri | 1952 |
Studies in the Arctic with the flicker-fusion nitroglycerin test; a new method of evaluating cardiovascular states.
Topics: Cardiovascular Diseases; Diagnostic Techniques, Cardiovascular; Nitroglycerin; Vision, Ocular | 1952 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Topics: Acetylcholine; Adenosine; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Co | 2004 |
Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.
Topics: Adult; Aged; Biomarkers; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Endothelium, | 2004 |
The response of the flicker fusion threshold to nitroglycerin and its potential value in the diagnosis, prognosis, and therapy of subclinical and clinical cardiovascular disease.
Topics: Cardiovascular Diseases; Flicker Fusion; Nitroglycerin; Prognosis; Vision, Ocular | 1950 |
Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Blood Pressure; Cardiovascular Diseases; Compliance; Female; | 2005 |
Cardiovascular risk factors in healthy women with previous gestational hypertension.
Topics: Adult; Blood Glucose; Body Composition; Brachial Artery; Carbohydrate Metabolism; Cardiovascular Dis | 2006 |
Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
Topics: Adipose Tissue; Administration, Sublingual; Adult; Aged; Biomarkers; Blood Glucose; Brachial Artery; | 2006 |
Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Topics: Administration, Sublingual; Adult; Anabolic Agents; Androgens; Blood Pressure; Cardiovascular Diseas | 2006 |
Glyceryl trinitrate (Anginine) use in a cardiovascular emergency.
Topics: Cardiovascular Diseases; Contraindications; Drug Tolerance; Humans; Nitroglycerin; Vasodilator Agent | 2006 |
Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteries; Blood Pressure; Brachial Artery; Cardiovascula | 2006 |
ESR techniques for the detection of nitric oxide in vivo as an index of endothelial function.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Carbazoles; Cardiovascular Diseases; Carvedilol; Cattle | 2006 |
The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brachial Artery; Cardiovascular Diseases; Echocardiograp | 2007 |
Venous or arterial endothelium evaluation for early cardiovascular dysfunction in hypertensive patients?
Topics: Acetylcholine; Adult; Arteries; Blood Glucose; Brachial Artery; Cardiovascular Diseases; Cardiovascu | 2007 |
Cross-sectional study of endothelial function in HIV-infected patients in Brazil.
Topics: Adolescent; Adult; Anti-HIV Agents; Body Mass Index; Brachial Artery; Brazil; Cardiovascular Disease | 2008 |
[Vasodilator therapy in cardiology].
Topics: Amyl Nitrite; Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Heart Failure; Hemodynamic | 1980 |
Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system.
Topics: Administration, Topical; Biological Availability; Cardiovascular Diseases; Delayed-Action Preparatio | 1983 |
A profile of intravenous nitroglycerin use in cardiopulmonary bypass surgery.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiovascular Diseases; Coronary Disease; Fema | 1983 |
Intravenous nitroglycerin: new uses for an old drug.
Topics: Cardiovascular Diseases; Cardiovascular System; Hemodynamics; Humans; Infusions, Parenteral; Nitrogl | 1983 |
Mortality from cardio-cerebrovascular diseases among dynamite workers--an extended case-referent study.
Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Humans; Male; Middle Aged; Nitrogly | 1984 |
Pharmacology and electrophysiology of calcium ion antagonists.
Topics: Calcium; Cardiovascular Diseases; Gallopamil; Heart; Humans; Myocardial Contraction; Nitroglycerin; | 1980 |
Pharmacologic intervention in cardiovascular nuclear medicine procedures.
Topics: Arteries; Blood Vessel Prosthesis; Cardiac Catheterization; Cardiovascular Diseases; Coronary Artery | 1981 |
Nitroglycerin: using a familiar drug in new ways.
Topics: Cardiovascular Diseases; Humans; Nitroglycerin; Patient Education as Topic; Self Administration | 1981 |
Drugs that alter nitric oxide homeostasis: a reply.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Nitric Oxide; Nitroglycer | 1994 |
Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure.
Topics: Adolescent; Adult; Aged; Aorta, Thoracic; Blood Pressure; Cardiac Catheterization; Cardiomyopathy, H | 1996 |
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac S
Topics: Anesthesia; Angioplasty, Balloon, Coronary; Cardiology; Cardiovascular Diseases; Coronary Artery Byp | 1996 |
Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation.
Topics: Analysis of Variance; Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular; Estradiol; Fe | 1997 |
Antiplasmin correlates to arterial reactivity in a healthy population of 35-year-old men and women.
Topics: Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brachial Artery; Cardiovascular Diseases; Endot | 1999 |
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
Topics: Adult; Blood Glucose; Brachial Artery; Cardiovascular Diseases; Case-Control Studies; Cholesterol, L | 1999 |
Vascular function correlates with risk factors for cardiovascular disease in a healthy population of 35-year-old subjects.
Topics: Adult; Blood Glucose; Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular; Female; Human | 1997 |
Transoesophageal acoustic quantification for evaluation of cardiac function during laparoscopic surgery.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiovascular Diseases; Cholecystectomy, Laparoscop | 2001 |
Gender difference in age-related changes in vascular function.
Topics: Adult; Aging; Blood Cell Count; Blood Pressure; Body Mass Index; Brachial Artery; Cardiovascular Dis | 2001 |
[Obstructive sleep apnea syndrome: a cardiovascular risk factor?].
Topics: Bradykinin; Cardiovascular Diseases; Data Interpretation, Statistical; Endothelium, Vascular; Follow | 2001 |
Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo.
Topics: Adult; Anatomy, Cross-Sectional; Arteries; Blood Pressure; Brachial Artery; Cardiovascular Diseases; | 2001 |
Impaired vascular reactivity is present despite normal levels of von Willebrand factor in patients with uncomplicated Type 2 diabetes.
Topics: Albuminuria; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitu | 2002 |
The problems of patients with cardiovascular disease undergoing dental treatment.
Topics: Anesthesia, Dental; Anesthesia, General; Anesthetics, Local; Anti-Bacterial Agents; Anticoagulants; | 1977 |
The army's view.
Topics: Cardiovascular Diseases; Environmental Exposure; Ethics, Medical; Government Agencies; Nitroglycerin | 1977 |
Usefulness of long-acting nitrates in cardiovascular disease.
Topics: Cardiovascular Diseases; Coronary Disease; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nit | 1978 |
Surgical complications of significance in dental practice.
Topics: Anesthesia, Dental; Anesthesia, Local; Angina Pectoris; Anticoagulants; Cardiovascular Diseases; Den | 1975 |
A symposium: 3rd North American Conference on Nitroglycerin Therapy. White Sulphur Springs, West Virginia, May 9-12, 1991.
Topics: Cardiovascular Diseases; Humans; Nitroglycerin | 1992 |
Cardiovascular mortality among munitions workers exposed to nitroglycerin and dinitrotoluene.
Topics: Adult; Cardiovascular Diseases; Cause of Death; Cerebrovascular Disorders; Cohort Studies; Coronary | 1992 |
Nitrates.
Topics: Cardiovascular Diseases; Coronary Disease; Drug Interactions; Hemodynamics; Humans; Isosorbide Dinit | 1992 |
Historical aspects of nitrate therapy.
Topics: Cardiovascular Diseases; History, 19th Century; History, 20th Century; Humans; Isosorbide Dinitrate; | 1987 |
[Modification of hemodynamic changes by the heart rate following sublingual administration of nitroglycerin--echocardiographic study].
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Pressure; Cardiac Output; Cardiovascular Diseas | 1985 |
[Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
Topics: Arterial Occlusive Diseases; Brain Ischemia; Cardiovascular Diseases; Coronary Disease; Drug Therapy | 1985 |
[Directed measures of the ambulatory scope of improvement of stationary care from the viewpoint of a specialist for cardiovascular diseases].
Topics: Adrenergic beta-Antagonists; Ambulatory Care; Cardiovascular Diseases; Coronary Disease; Heart Defec | 1974 |
[Medicamentous prophylaxis of postoperative cardiovascular complications (author's transl)].
Topics: Aged; Cardiovascular Diseases; Digitalis Glycosides; Dipyridamole; Female; Humans; Male; Middle Aged | 1974 |
The mechanism of action of cardiovascular drugs and their clinical effectiveness.
Topics: Cardiovascular Diseases; Digitalis Glycosides; Humans; Nitroglycerin; Plants, Medicinal; Quinidine; | 1966 |
[The experimental production of cardiovascular diseases in monkeys].
Topics: Animals; Arteriosclerosis; Atropine; Cardiovascular Diseases; Cholesterol; Coronary Disease; Diet, A | 1966 |
[Value of clinico-pharmaco-dynamic tests in phonomechanography].
Topics: Adolescent; Adult; Amyl Nitrite; Angiocardiography; Cardiovascular Diseases; Female; Humans; Kinetoc | 1968 |